Eastman Chemical Company (EMN) Stock Price & How to Invest

Eastman Chemical Company (NYSE: EMN) is a global specialty materials producer headquartered in Kingsport, Tennessee, organized into four segments: Advanced Materials (specialty films, plastics, and interlayers), Additives and Functional Products (coatings, inks, and performance additives), Chemical Intermediates (commodity and functional chemicals), and Fibers (cellulose acetate tow, largely for cigarette filters). Trailing-twelve-month revenue is about $8.9 billion, and the company has leaned into circular-economy positioning through its Kingsport methanolysis (molecular recycling) plant, which converts hard-to-recycle plastic waste back into raw materials and added roughly $60 million of incremental earnings in 2025.

The investment picture is that of a mature, cyclical chemicals company. As of October 16, 2026 the stock closed near $63.26, giving a market cap around $7.2 billion, a trailing P/E near 16.5 and a forward P/E under 10 on consensus estimates. Bulls point to the ~5.3% dividend yield, the specialty mix that is meant to be less commodity-like over time, the recycling growth optionality, and an improving earnings run: Q2 2026 revenue rose to about $2.51 billion with net income of ~$183 million and adjusted EPS of $1.97, ahead of the ~$1.82 consensus. Bears note that trailing profit margins are thin (about 5%), the payout ratio on GAAP earnings is near 87%, and several brokers have cut targets in October (JPMorgan downgraded to Neutral with a $66 target, RBC trimmed to $65). The shares are down about 1.7% year to date and up about 5.2% over one year, well below the 52-week high of ~$83.47, so the debate is still about whether specialty volumes and chemical spreads recover.

Eastman is cyclical and sensitive to global industrial demand, energy and raw-material costs, and destocking, all of which pressured 2025 and early 2026 results (2025 net earnings fell to ~$474 million from ~$905 million in 2024). The Fibers segment relies heavily on cellulose acetate tow for cigarette filters, a structurally declining end market. Weak Chemical Intermediates spreads, softer consumer discretionary demand, and energy-cost spikes can compress margins quickly. The recycling growth thesis carries execution and offtake-demand risk. The ~5.3% dividend, at roughly 87% of trailing GAAP earnings, depends on the earnings recovery analysts expect actually arriving, and October brought a JPMorgan downgrade plus several price-target cuts.

16 analysts publish price targets on EMN, averaging $76.19 against a $62.33 price as of October 2026, or +22.2%. The published targets run from $65.00 to $87.00, a narrow spread, and the ratings split 8 buy, 9 hold, 0 sell. Over the last six months there have been 2 raises and 8 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full EMN forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Eastman Chemical Company. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Molecular recycling ramp. Eastman's Kingsport methanolysis facility is the centerpiece of its circular-economy pitch, converting plastic waste into feedstock. The most optimistic published target, $87.00, assumes this works close to its best case.

The case against. Eastman is cyclical and sensitive to global industrial demand, energy and raw-material costs, and destocking, all of which pressured 2025 and early 2026 results (2025 net earnings fell to ~$474 million from ~$905 million in 2024). The most pessimistic target, $65.00, is roughly what EMN is worth if this bites instead.

Read the full bull and bear case on EMN, including what would have to change to break either one. Walnut is not an investment adviser.

No. Eastman Chemical Company (EMN) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Eastman Chemical Company's investor relations page or your broker.

• Revenue (TTM): ~$8.9B
• Revenue growth (Q2 2026, yoy): ~+10%
• Net income (TTM): ~$442M (~5% margin)
• Q2 2026 adjusted EPS: $1.97 vs ~$1.82 est.
• P/E (trailing / forward): ~16.5 / ~9.5
• Dividend yield: ~5.3%
• Market cap: ~$7.2B
• Operating cash flow (TTM): ~$991M

Eastman closed near $63 on October 16, 2026 for a market cap around $7.2 billion, down ~1.7% YTD and ~24% below its 52-week high. A forward P/E under 10 and a ~5.3% yield price in skepticism that consensus 2026 EPS of ~$6.32 will hold, despite a Q2 beat. The Q3 report on October 29 (consensus ~$1.92 EPS on ~$2.4 billion revenue) is the next test.

If you want EMN exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

These are the investment theses EMN naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to EMN: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get EMN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (IJS, SLYV), which spreads the position across many companies. Or build it into a focused thematic portfolio, so EMN sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where EMN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

EMN is a cyclical specialty-chemicals dividend stock whose story hinges on a demand recovery and its Kingsport recycling ramp. A solid Q2 2026 beat has not lifted the shares (about $63, down ~2% YTD), so it tends to attract income and value-oriented investors rather than growth buyers, with the Q3 report on October 29 as the next checkpoint.

Whether EMN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is EMN a buy or a sell?, and where the stock could go from here in the EMN stock forecast.

For income investors, whether EMN pays a dividend and how the payout looks is covered in does EMN pay a dividend? And to weigh EMN against a peer, read the full side-by-side comparisons: EMN vs CELH and EMN vs CROX.